A recent study published in JAMA has found that the benefits of hormone therapy for menopause outweigh the risks, according to study author Dr. JoAnn Manson, chief of preventive medicine at Brigham and Women’s Hospital. The study, based on two decades of data from the Women’s Health Initiative study, showed that different types of hormones delivered at lower doses are safer for women under 60.
Dr. Lauren Streicher, a clinical professor of obstetrics and gynecology at Northwestern University Feinberg School of Medicine, confirmed that some risks identified in the initial study were linked to specific types of hormones. Micronized progesterone and transdermal estrogen are now recommended as safer options for hormone therapy.
In addition to treating hot flashes, hormone therapy may also offer benefits such as protection against bone loss and heart disease. Women are advised to discuss hormone therapy options with their healthcare providers based on their individual needs and risks.
This new research provides important insights into the safety and effectiveness of hormone therapy for menopause. With the recommendation of safer options such as micronized progesterone and transdermal estrogen, women can now make more informed decisions about their menopausal treatment. It is crucial for women to consult with their healthcare providers to determine the best hormone therapy plan for their specific needs.
“Social media scholar. Reader. Zombieaholic. Hardcore music maven. Web fanatic. Coffee practitioner. Explorer.”